Leap Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Leap Investments’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24,931	Closed	-$244K	–	629
2019 Q4	$244K	Buy	+24,931	New	+$234K	0.11%	283

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Leap Investments's VIVO Position: Q1 2020 in Review

Leap Investments sold out of Meridian Bioscience Inc (VIVO) in Q1 2020, closing a stake of 24,931 shares — an estimated $244K sold.

Leap Investments first reported a position in VIVO in Q4 2019 and held it in 1 quarter. The position peaked at $244K in Q4 2019. 168 funds tracked by Wall St. Rank hold VIVO as of Q1 2020.

Leap Investments reported no remaining Meridian Bioscience Inc position as of Q1 2020 after selling out during the quarter.
Leap Investments sold 24,931 Meridian Bioscience Inc shares in Q1 2020, an estimated $244K.
Leap Investments first reported a position in Meridian Bioscience Inc in Q4 2019 and held it in 1 quarter.
Leap Investments's Meridian Bioscience Inc position peaked at $244K in Q4 2019.
168 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2020.

Based on Leap Investments's 13F filing for Q1 2020, filed 15 May 2020.